Effects [qlco]    
Drugs, Antidiabetic [phsu]    
Antioxidant [phsu]    
Liver Function Test [lbpr]    
Marker [clna]    
DIABETES MELLITUS, TYPE II [dsyn]    
Subject [grup]    
Pilot [prog]    
Study Objective [idcn]    
Present [qnco]    
Study [mnob]    
Effects [qlco]    
Drugs, Antidiabetic [phsu]    
Antioxidant [phsu]    
Liver Function Test [lbpr]    
Marker [clna]    
Association [menp]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Type 2 [clas]    
DIABETIC [fndg]    
Subject [grup]    
Methods [inpr]    
Assessed [acty]    
Healthy [qlco]    
DIABETIC [fndg]    
Subject [grup]    
DIABETIC [fndg]    
Subject [grup]    
Divided [ftcn]    
Based [ftcn]    
On [ftcn]    
treatment [ftcn]    
Combination [qlco]    
Drugs, Antidiabetic [phsu]    
Combination [qlco]    
Drugs, Antidiabetic [phsu]    
Liver Function Test [lbpr]    
Marker [clna]    
Antioxidant [phsu]    
Status [qlco]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Assessed [acty]    
Subject [grup]    
superoxide dismutase activity [moft]    
Higher [qlco]    
catalase activity [moft]    
LOWER [spco]    
DIABETIC [fndg]    
Subject [grup]    
Compared [acty]    
control [qlco]    
Levels [qlco]    
Higher [qlco]    
DIABETIC [fndg]    
MALE [orga]    
Subject [grup]    
Levels [qlco]    
LOWER [spco]    
Levels [qlco]    
Higher [qlco]    
DIABETIC [fndg]    
FEMALE [orga]    
Subject [grup]    
MALE [orga]    
Subject [grup]    
Association [menp]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Seen [qlco]    
Association [menp]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Seen [qlco]    
Males [orga]    
Receive [qlco]    
Drugs [phsu]    
FEMALE [orga]    
Subject [grup]    
displayed [ftcn]    
Association [menp]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Association [menp]    
Homeostasis model assessment [hlca]    
INSULIN RESISTANCE [patf]    
Seen [qlco]    
Females [orga]    
Combination [qlco]    
diabetic Drugs [bmod]    
Alteration [idcn]    
antioxidant activity [moft]    
Liver Function Tests [lbpr]    
Dependent [qlco]    
Gender [orga]    
glycemia status [fndg]    
Subject [grup]    
variations [qlco]    
Correlation [qlco]    
Homeostasis model assessment [hlca]    
INSULIN RESISTANCE [patf]    
Antioxidant [phsu]    
Liver Function Tests [lbpr]    
Inflammatory [ftcn]    
Marker [clna]    
Dependent [qlco]    
TYPE [qlco]    
Treatments [topp]    
